Search

everythinglearnresearchcommunity

for

Search:↓

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Anthralin is effective for psoriasis and alopecia with minimal systemic side effects but can irritate the skin.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Injectable Platelet-Rich Fibrin (I-PRF) showed positive results for treating hair loss, skin texture, wrinkles, and wounds.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Bioaesthetic therapies could improve healthcare if they safely regenerate cells, tissues, or organs to restore normal function.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The combination therapy was effective and well-tolerated, especially in young patients.

Gold nanoparticles show promise for treating inflammatory bowel disease by reducing inflammation and colon injury.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

New hybrid compound found to effectively prevent hair loss.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.